• Citer

Factors associated with surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial.

par Criscitiello, Carmen ;Abdel Azim, Hatem Hamdy ;Agbor-Tarh, Dominique;de Azambuja, Evandro ;Piccart, P;Baselga, José;Eidtmann, Holger;Di Cosimo, Serena;Bradbury, Ian;Rubio, Isabel Teresa
Référence Annals of oncology, 24, 8, page (1980-1985)
Publication Publié, 2013-08

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Factors associated with surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial.
Auteur:	Criscitiello, Carmen; Abdel Azim, Hatem Hamdy; Agbor-Tarh, Dominique; de Azambuja, Evandro; Piccart, P; Baselga, José; Eidtmann, Holger; Di Cosimo, Serena; Bradbury, Ian; Rubio, Isabel Teresa
Informations sur la publication:	Annals of oncology, 24, 8, page (1980-1985)
Statut de publication:	Publié, 2013-08
Sujet CREF:	Cancérologie
Mots-clés:	Breast cancer
	Breast conservation
	HER2
	Neoadjuvant
	Surgery
	Trastuzumab
MeSH keywords:	Adult
	Antibodies, Monoclonal, Humanized -- therapeutic use
	Antineoplastic Agents, Phytogenic -- therapeutic use
	Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
	Breast Neoplasms -- drug therapy -- surgery
	Decision Making
	Female
	Humans
	Mastectomy, Segmental
	Middle Aged
	Neoadjuvant Therapy
	Paclitaxel -- therapeutic use
	Quinazolines -- therapeutic use
	Receptor, ErbB-2 -- metabolism
	Receptors, Estrogen -- metabolism
	Treatment Outcome
	Young Adult
Note générale:	Journal Article
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0923-7534
	info:doi/10.1093/annonc/mdt129
	info:pii/mdt129
	info:scp/84881227399
	info:pmid/23567146